Press What’s news at AbelsonTaylor Group
Select category
Health Literacy and Rare Disease
In a discussion about health literacy, MedAdNews talks to AT’s Sharlene Jenner, VP – Director of Engagement Strategy, and Mike Czuba, VP – Insights Innovation, about AbelsonTaylor’s approach to getting the right message to the right patient in the rare disease space.
Read more at Med Ad News/PharmaLive
Media Contact:
Recent Posts
AbelsonTaylor Group Named PM360 Trailblazer Finalists in Nine Categories
AbelsonTaylor Group has been named a finalist in nine categories of the 2023 Trailblazer Awards. The finalists are: Professional Website/Online...
Read Press Read more AbelsonTaylor Group Named PM360 Trailblazer Finalists in Nine CategoriesSeres Therapeutics and Nestle Health Science Marketing Teams Named PM360 Trailblazer 2023 Finalist For Marketing Team of The Year
PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, has named Seres Therapeutics...
Read Press Read more Seres Therapeutics and Nestle Health Science Marketing Teams Named PM360 Trailblazer 2023 Finalist For Marketing Team of The YearThe AI Revolution Has Arrived: Shaping the Next Generation of Pharma Marketing
Sharlene Jenner – VP Director of Engagement Strategy is joined by five industry professionals to discuss the impact AI has...
In the News Read more The AI Revolution Has Arrived: Shaping the Next Generation of Pharma MarketingConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising
